Black Diamond Therapeutics Inc (BDTX)

[dcaf7]

From BB Biotech (BION), a Switzerland-based investment company,
"Notable recent transactions include an addition to the company’s holding in Black Diamond Therapeutics, a targeted oncology player. Promising clinical data on BDTX-1535, a treatment for lung cancer, allowed Black Diamond to undertake a capital raising. BION made an additional investment to maintain its 15% ownership stake in the company. Exposure to Black Diamond was raised further via open market transactions. The managers like this company in part due to its deployment of massive computational power and machine learning to deepen its understanding of disease processes and speed up the identification and development of new treatments".
https://www.edisongroup.com/research/a-cutting-edge-sector-and-a-high-dividend/32799/